These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22244937)

  • 1. Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor.
    Plantevin Krenitsky V; Nadolny L; Delgado M; Ayala L; Clareen SS; Hilgraf R; Albers R; Hegde S; D'Sidocky N; Sapienza J; Wright J; McCarrick M; Bahmanyar S; Chamberlain P; Delker SL; Muir J; Giegel D; Xu L; Celeridad M; Lachowitzer J; Bennett B; Moghaddam M; Khatsenko O; Katz J; Fan R; Bai A; Tang Y; Shirley MA; Benish B; Bodine T; Blease K; Raymon H; Cathers BE; Satoh Y
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1433-8. PubMed ID: 22244937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury.
    Krenitsky VP; Delgado M; Nadolny L; Sahasrabudhe K; Ayala L; Clareen SS; Hilgraf R; Albers R; Kois A; Hughes K; Wright J; Nowakowski J; Sudbeck E; Ghosh S; Bahmanyar S; Chamberlain P; Muir J; Cathers BE; Giegel D; Xu L; Celeridad M; Moghaddam M; Khatsenko O; Omholt P; Katz J; Pai S; Fan R; Tang Y; Shirley MA; Benish B; Blease K; Raymon H; Bhagwat S; Henderson I; Cole AG; Bennett B; Satoh Y
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1427-32. PubMed ID: 22226655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.
    Lim AK; Ma FY; Nikolic-Paterson DJ; Ozols E; Young MJ; Bennett BL; Friedman GC; Tesch GH
    Am J Nephrol; 2011; 34(4):337-46. PubMed ID: 21876346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase.
    Selness SR; Devraj RV; Devadas B; Walker JK; Boehm TL; Durley RC; Shieh H; Xing L; Rucker PV; Jerome KD; Benson AG; Marrufo LD; Madsen HM; Hitchcock J; Owen TJ; Christie L; Promo MA; Hickory BS; Alvira E; Naing W; Blevis-Bal R; Messing D; Yang J; Mao MK; Yalamanchili G; Vonder Embse R; Hirsch J; Saabye M; Bonar S; Webb E; Anderson G; Monahan JB
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4066-71. PubMed ID: 21641211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead optimization of isocytosine-derived xanthine oxidase inhibitors.
    Bajaj K; Burudkar S; Shah P; Keche A; Ghosh U; Tannu P; Khanna S; Srivastava A; Deshmukh NJ; Dixit A; Ahire Y; Damre A; Nemmani KV; Kulkarni-Almeida A; B-Rao C; Sharma R; Sivaramakrishnan H
    Bioorg Med Chem Lett; 2013 Feb; 23(3):834-8. PubMed ID: 23265878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacement.
    Neitz RJ; Konradi AW; Sham HL; Zmolek W; Wong K; Qin A; Lorentzen C; Nakamura D; Quinn KP; Sauer JM; Powell K; Ruslim L; Chereau D; Ren Z; Anderson J; Bard F; Yednock TA; Griswold-Prenner I
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3726-9. PubMed ID: 21570836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel tricyclic inhibitors of IKK2: discovery and SAR leading to the identification of 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-yl)pyridin-2-yl)methyl)acetamide (BMS-066).
    Watterson SH; Langevine CM; Van Kirk K; Kempson J; Guo J; Spergel SH; Das J; Moquin RV; Dyckman AJ; Nirschl D; Gregor K; Pattoli MA; Yang X; McIntyre KW; Yang G; Galella MA; Booth-Lute H; Chen L; Yang Z; Wang-Iverson D; McKinnon M; Dodd JH; Barrish JC; Burke JR; Pitts WJ
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7006-12. PubMed ID: 22018461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.
    Bonnefous C; Payne JE; Roppe J; Zhuang H; Chen X; Symons KT; Nguyen PM; Sablad M; Rozenkrants N; Zhang Y; Wang L; Severance D; Walsh JP; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND
    J Med Chem; 2009 May; 52(9):3047-62. PubMed ID: 19374401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia.
    Ho GD; Yang SW; Smotryski J; Bercovici A; Nechuta T; Smith EM; McElroy W; Tan Z; Tulshian D; McKittrick B; Greenlee WJ; Hruza A; Xiao L; Rindgen D; Mullins D; Guzzi M; Zhang X; Bleickardt C; Hodgson R
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1019-22. PubMed ID: 22222034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitors.
    Yun W; Ahmad M; Chen Y; Gillespie P; Conde-Knape K; Kazmer S; Li S; Qian Y; Taub R; Wertheimer SJ; Whittard T; Bolin D
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7205-9. PubMed ID: 22001092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1).
    Asano Y; Kitamura S; Ohra T; Aso K; Igata H; Tamura T; Kawamoto T; Tanaka T; Sogabe S; Matsumoto S; Yamaguchi M; Kimura H; Itoh F
    Bioorg Med Chem; 2008 Apr; 16(8):4715-32. PubMed ID: 18313304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.
    Montalban AG; Boman E; Chang CD; Ceide SC; Dahl R; Dalesandro D; Delaet NG; Erb E; Ernst J; Gibbs A; Kahl J; Kessler L; Lundström J; Miller S; Nakanishi H; Roberts E; Saiah E; Sullivan R; Wang Z; Larson CJ
    Eur J Pharmacol; 2010 Apr; 632(1-3):93-102. PubMed ID: 20132813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.
    Hu Y; Xiang JS; DiGrandi MJ; Du X; Ipek M; Laakso LM; Li J; Li W; Rush TS; Schmid J; Skotnicki JS; Tam S; Thomason JR; Wang Q; Levin JI
    Bioorg Med Chem; 2005 Dec; 13(24):6629-44. PubMed ID: 16216515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery.
    Erlanson DA; Arndt JW; Cancilla MT; Cao K; Elling RA; English N; Friedman J; Hansen SK; Hession C; Joseph I; Kumaravel G; Lee WC; Lind KE; McDowell RS; Miatkowski K; Nguyen C; Nguyen TB; Park S; Pathan N; Penny DM; Romanowski MJ; Scott D; Silvian L; Simmons RL; Tangonan BT; Yang W; Sun L
    Bioorg Med Chem Lett; 2011 May; 21(10):3078-83. PubMed ID: 21459573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-anilino-4-aryl-8H-purine derivatives as inhibitors of PDK1.
    Blanchard S; Soh CK; Lee CP; Poulsen A; Bonday Z; Goh KL; Goh KC; Goh MK; Pasha MK; Wang H; Williams M; Wood JM; Ethirajulu K; Dymock BW
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2880-4. PubMed ID: 22437109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid identification of the pharmacophore in a peptoid inhibitor of the proteasome regulatory particle.
    Lim HS; Archer CT; Kim YC; Hutchens T; Kodadek T
    Chem Commun (Camb); 2008 Mar; (9):1064-6. PubMed ID: 18292891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor.
    Bowers S; Truong AP; Neitz RJ; Neitzel M; Probst GD; Hom RK; Peterson B; Galemmo RA; Konradi AW; Sham HL; Tóth G; Pan H; Yao N; Artis DR; Brigham EF; Quinn KP; Sauer JM; Powell K; Ruslim L; Ren Z; Bard F; Yednock TA; Griswold-Prenner I
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1838-43. PubMed ID: 21316234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of
    Koralewski R; Dymek B; Mazur M; Sklepkiewicz P; Olejniczak S; Czestkowski W; Matyszewski K; Andryianau G; Niedziejko P; Kowalski M; Gruza M; Borek B; Jedrzejczak K; Bartoszewicz A; Pluta E; Rymaszewska A; Kania M; Rejczak T; Piasecka S; Mlacki M; Mazurkiewicz M; Piotrowicz M; Salamon M; Zagozdzon A; Napiorkowska-Gromadzka A; Bartlomiejczak A; Mozga W; Dobrzański P; Dzwonek K; Golab J; Nowotny M; Olczak J; Golebiowski A
    J Med Chem; 2020 Dec; 63(24):15527-15540. PubMed ID: 33078933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and optimization of indoles and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-I).
    Chowdhury S; Sessions EH; Pocas JR; Grant W; Schröter T; Lin L; Ruiz C; Cameron MD; Schürer S; LoGrasso P; Bannister TD; Feng Y
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7107-12. PubMed ID: 22004718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.